Healthcare Life Science & Chemical Instrumentation Market Size, Share, Analysis Report

Healthcare Life Science & Chemical Instrumentation Market By Technology Analysis (Chromatography, Electrophoresis, DNA sequencers & amplifiers, Lab automation, Flow cytometry, Spectroscopy, Microarray, Immunoassay); By End User Analysis (Pharmaceutical, Biopharmaceutical & biotechnology companies, Clinical research organizations, Academic institutions, Hospitals, Clinics & diagnostic laboratories, Forensic science laboratories, Food & agriculture industry, Environmental testing industry) and By Regional Analysis – Global Forecast by

The Global Healthcare Life Science & Chemical Instrumentation Market is expected to be around US$ 78.20 billion by 2028 and will grow at a CAGR of more than 6% in the given forecast period.

Purchase User License

MARKET SNAPSHOT

Major Players

Study period:

2023-2028

Base Year:

2022

CAGR:

6

Fastest Growing Market:

APAC

Largest Market:

North America

REPORT DESCRIPTION

Lifestyles science and chemical instrumentation is utilized in research & development activities in business laboratories, biotechnology industry, pharmaceutical industries, and academic institutes. It is also used in trying out the excellent of food products, laboratory information management device, and screen & manipulate manner in production plants. The chemical properties and composition is studies with the assist of lifestyles technological know-how and chemical instrumentation. As a consequence, these devices play good sized role in scientific evaluation of dwelling organism in biotechnology and molecular biology. A favorable government regulation for pharmaceutical R&D in rising countries and developing food protection concerns fuels the growth of the arena existence technological know-how and chemical instrumentation marketplace.
 
How Big is the Global Healthcare Life Science & Chemical Instrumentation Market?

The Global Healthcare Life Science & Chemical Instrumentation Market is expected to be around US$ 78.20 billion by 2028 and will grow at a CAGR of more than 6% in the given forecast period.

The major driving factors of Global Healthcare Life Science & Chemical Instrumentation Market are as follows:
 
•    Technical advancements in logical devices supplements growth
•    Rising environmental safety concerns 
•    Rising proteomics market
•    Requirement from applied markets
 
The restraining factors of Global Healthcare Life Science & Chemical Instrumentation Market are as follows:
 
•    High rate of instruments 
•    Existence of alternative technologies 
 
The Global Healthcare Life Science & Chemical Instrumentation Market is segmented on the lines of its technology, end user and regional. Based on technology segmentation it covers chromatography, electrophoresis, DNA sequencers & amplifiers, lab automation, flow cytometry, spectroscopy, microarray, immunoassay and other instruments. Under end user segmentation it covers pharmaceutical, biopharmaceutical & biotechnology companies, clinical research organizations, academic institutions, hospitals, clinics & diagnostic laboratories, forensic science laboratories, Food & agriculture industry and environmental testing industry. The Global Healthcare Life Science & Chemical Instrumentation Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

This report provides:
 
1) An overview of the global market for healthcare life science & chemical instrumentation and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Global Healthcare Life Science & Chemical Instrumentation Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
 
REPORT SCOPE:
  
The scope of the report includes a detailed study of global and regional markets for Global Healthcare Life Science & Chemical Instrumentation Market with the reasons given for variations in the growth of the industry in certain regions.
 
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Agilent Technologies Inc., Bio-Rad Laboratories Inc., Becton, Dickinson, & Company, Bruker Corporation, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., PerkinElmer Inc., Danaher Corporation, Shimadzu Corporation, and Waters Corporation Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments. 
 
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
  
The Global Healthcare Life Science & Chemical Instrumentation Market has been segmented as below:
By Technology Analysis

•    Chromatography
•    Electrophoresis
•    DNA sequencers & amplifiers 
•    Lab automation
•    Flow cytometry
•    Spectroscopy
•    Microarray
•    Immunoassay
•    Other instruments
By End User Analysis

•    Pharmaceutical
•    Biopharmaceutical& biotechnology companies 
•    Clinical research organizations
•    Academic institutions 
•    Hospitals
•    Clinics& diagnostic laboratories 
•    Forensic science laboratories 
•    Food& agriculture industry 
•    Environmental testing industry
 
By Regional Analysis

•    North America
•    Europe
•    Asia-Pacific
•    Rest of the World

Reasons to Buy this Report: 
1) Obtain the most up to date information available on all Global Healthcare Life Science & Chemical Instrumentation Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Healthcare Life Science & Chemical Instrumentation Market data.
4) Assess your competitor’s refining portfolio and its evolution.

Customization: 
 
We can offer you custom research reports as per client’s special requirements.

Below are our new reports:

Breast Pump market

breast pumps market

Breathing Circuits Market

Burn Care Products & Accessories market

CA 125 Test Market

1 INTRODUCTION     

    1.1    Key Take Aways    
    1.2    Report Description    
    1.3    Markets Covered    
    1.4    Stakeholders    
    1.5    Research Methodology    
        1.5.1    Market Size    
        1.5.2    Market Share    
        1.5.3    Key Data Points From Secondary Sources    
        1.5.4    Key Data Points From Primary Sources

 

2 Research Methodology
    2.1 Research Methodology Steps
    2.2 Secondary and Primary Research Methodology
           2.2.1 Secondary Research
                    2.2.1.1 Key Data From Secondary Sources
           2.2.2 Primary Research
                    2.2.2.1 Breakdown of Primaries
                    2.2.2.2 Key Data From Primary Sources
    2.3 Life Science Instrumentation Market Size Estimation
                    2.3.1.1 Bottom-Up Approach
                    2.3.1.2 Top-Down Approach
    2.4 Research Design
    2.5 Life Science Instrumentation Market Breakdown and Data Triangulation
    2.6 Research Assumptions

 

3 Executive Summary
    3.1 Introduction
    3.2 Current Scenario
    3.3 Future Outlook
    3.4 Conclusion

 

4 Premium Insights
    4.1 Global Life Science Instrumentation Market Overview
    4.2 Geographic Analysis: Life Science Instrumentation Market, By Technology, 2016
    4.3 Life Science Instrumentation Market, By Application (2016 vs 2021)
    4.4 Geographical Snapshot of the Life Science Instrumentation Market, 2016
    4.5 Life Cycle Analysis, By Region

 

5 Market Overview
    5.1 Introduction
    5.2 Life Science Instrumentation Market Segmentation
    5.3 Life Science Instrumentation Market Dynamics
           5.3.1 Drivers
                    5.3.1.1 Increasing Spending on Pharmaceutical R&D Across the Globe
                    5.3.1.2 Growing Food Safety Concerns
                    5.3.1.3 Technological Advancements in Analytical Devices
                    5.3.1.4 Growth in Funding for Research
           5.3.2 Restraints
                    5.3.2.1 High Cost of Instruments
                    5.3.2.2 Presence of Alternative Technologies
                    5.3.2.3 Dearth of Skilled Professionals
           5.3.3 Opportunities
                    5.3.3.1 Emerging Markets Offer Lucrative Growth Opportunities
                    5.3.3.2 Rising Demand of Analytical Instruments With Growing Research Activities in Proteomics
                    5.3.3.3 Increasing Demand From Various Industries
           5.3.4 Challenges
                    5.3.4.1 Inadequate Infrastructure for Research in Emerging Countries
                    5.3.4.2 Survival of Small Players

 

6 Industry Insights
    6.1 Introduction
    6.2 Value Chain Analysis
    6.3 Life Science Instrumentation Market Indicators
           6.3.1 Increasing R&D Spending in the Pharmaceutical and Biotech Sectors
    6.4 Industry Trends
           6.4.1 Rising Focus of Market Players Towards the Development of Miniaturized Instruments
           6.4.2 Increasing Adoption of Hyphenated Technologies
           6.4.3 Tie-Ups Between Analytical Instrument Manufacturers and Research Laboratories/Academic Institutions
    6.5 Porter’s Five Forces Analysis
           6.5.1 Threat of New Entrants
           6.5.2 Threat From Substitutes
           6.5.3 Bargaining Power of Suppliers
           6.5.4 Bargaining Power of Buyers
           6.5.5 Intensity of Competitive Rivalry

 

7 Life Science Instrumentation Market, By Technology
    7.1 Introduction
    7.2 Spectroscopy
           7.2.1 Drivers
                    7.2.1.1 Atomic Spectroscopy to Aid in Drug Safety Process
           7.2.2 Restraints
                    7.2.2.1 High Costs
           7.2.3 Spectroscopy Market, By Type
                    7.2.3.1 Molecular Spectroscopy
                               7.2.3.1.1 Market Share Analysis, By Key Player
                    7.2.3.2 Mass Spectrometry
                               7.2.3.2.1 Market Share Analysis, By Key Player
                    7.2.3.3 Atomic Spectroscopy
                               7.2.3.3.1 Market Share Analysis, By Key Player
    7.3 Chromatography
           7.3.1 Drivers
                    7.3.1.1 New International Gmp & Gdp Certification for Pharmaceutical Excipients (North America & Europe): Excipact
                    7.3.1.2 Industry Support to Research Laboratories and Academic Institutes
                    7.3.1.3 Rise in Government Investments for Chromatography Technologies
                    7.3.1.4 Growing Importance of Chromatography Tests in Drug Approvals
           7.3.2 Restraints
                    7.3.2.1 High Cost of Equipment
           7.3.3 Chromatography Market, By Type
                    7.3.3.1 Liquid Chromatography (LC) Systems
                    7.3.3.2 Gas Chromatography (GC) Systems
                    7.3.3.3 Supercritical Fluid Chromatography (SFC) Systems
                    7.3.3.4 Thin-Layer Chromatography (TLC) Systems
           7.3.4 Market Share Analysis, By Key Player
    7.4 Microscopy
           7.4.1 Drivers
                    7.4.1.1 Rising Focus on Nanotechnology
                    7.4.1.2 Public-Private Investments for the Development of Advanced Microscopes
                    7.4.1.3 Technological Advancements
           7.4.2 Restraints
                    7.4.2.1 High Cost of Advanced Microscopes
           7.4.3 Microscopy Market, By Type
                    7.4.3.1 Optical Microscopy
                               7.4.3.1.1 Market Share Analysis, By Key Player
                    7.4.3.2 Electron Microscopy
                               7.4.3.2.1 Market Share Analysis, By Key Player
                    7.4.3.3 Scanning Probe Microscopy
                               7.4.3.3.1 Market Share Analysis, By Key Player
                    7.4.3.4 Confocal Microscopy
                               7.4.3.4.1 Market Share Analysis, By Key Player
    7.5 PCR
           7.5.1 Drivers
                    7.5.1.1 Rising Incidences of Infectious Diseases and Genetic Disorders
                    7.5.1.2 Technological Advancements
           7.5.2 Restraints
                    7.5.2.1 High Device Costs Associated With DPCR
                    7.5.2.2 Technical Limitations of QPCR and DPCR
           7.5.3 PCR Market, By Type
                    7.5.3.1 QPCR
                               7.5.3.1.1 QPCR Market Share Analysis (2015)
                    7.5.3.2 Digital PCR (DPCR)
                               7.5.3.2.1 DPCR Market Share Analysis (2015)
    7.6 Flow Cytometry
           7.6.1 Drivers
                    7.6.1.1 Technological Advancements in Flow Cytometry Instruments
                    7.6.1.2 Growing Adoption of Flow Cytometry Techniques in Research Activities
           7.6.2 Restraints
                    7.6.2.1 High Cost of Instruments
                    7.6.2.2 Lack of Awareness and Dearth of Training
           7.6.3 Flow Cytometry Market, By Type
                    7.6.3.1 Cell-Based Flow Cytometry
                    7.6.3.2 Bead-Based Flow Cytometry
           7.6.4 Market Share Analysis, By Key Player
    7.7 Immunoassays
           7.7.1 Drivers
                    7.7.1.1 Rising Incidence of Chronic and Infectious Diseases in Emerging Economies
                    7.7.1.2 Sensitivity, Low Cost, and Rapid Analysis Offered By Immunoassays
                    7.7.1.3 Increasing Health Awareness
           7.7.2 Restraints
                    7.7.2.1 Low Detection Restricts Adoption of Immunoassay Tests
           7.7.3 Market Share Analysis, By Key Player
    7.8 Liquid Handling and Robotics
           7.8.1 Drivers
                    7.8.1.1 Rising Labor Costs Driving the Need for Automation
                    7.8.1.2 Technological Advancements to Boost the Adoption of Liquid Handling and Robotics Systems
           7.8.2 Restraints
                    7.8.2.1 Reluctance of Small and Medium-Sized Labs Towards the Adoption of Automation
           7.8.3 Liquid Handling Market, By Type
                    7.8.3.1 Automatic Liquid Handling
                    7.8.3.2 Manual Liquid Handling
           7.8.4 Standalone Robots Market, By Type
                    7.8.4.1 Robotic Arms
                    7.8.4.2 Track Robot Systems
    7.9 Centrifuges
           7.9.1 Drivers
                    7.9.1.1 Technological Advancements
                    7.9.1.2 Increasing Biopharmaceutical Research Activities
           7.9.2 Restraints
                    7.9.2.1 Long Equipment Lifespan Leads to Low Sales of Centrifuges
           7.9.3 Centrifuges Market, By Type
                    7.9.3.1 Microcentrifuges
                    7.9.3.2 Multipurpose Centrifuges
                    7.9.3.3 Floor-Standing Centrifuges
                    7.9.3.4 Ultracentrifuges
           7.9.4 Market Share Analysis, By Key Player
    7.10 Electrophoresis
           7.10.1 Drivers
                    7.10.1.1 Increasing Government Funding for Research on Electrophoresis Technique
                    7.10.1.2 Growing Number of Industry-Academic Research Collaborations
                    7.10.1.3 Growing Use of Capillary Electrophoresis (CE) With Mass Spectroscopy (MS)
           7.10.2 Restraints
                    7.10.2.1 Presence of Alternative Technologies Offering Better Efficiency & Results
                    7.10.2.2 Time-Consuming Operations and Limited Sample Analysis
           7.10.3 Electrophoresis Market, By Type
                    7.10.3.1 Gel Electrophoresis Systems
                    7.10.3.2 Capillary Electrophoresis Systems
           7.10.4 Market Share Analysis, By Key Player
    7.11 Cell Counting
           7.11.1 Drivers
                    7.11.1.1 Growing Application in Diagnosis of Cancer and Aids
                    7.11.1.2 Corporate & Government Funding and Investments for Cell-Based Research
                    7.11.1.3 Development of Enhanced Informatics Solutions and Improved Image Analysis Instruments
           7.11.2 Restraints
                    7.11.2.1 High Prices of Advanced Cell Counting Systems
                    7.11.2.2 Reluctance Among Researchers to Use Advanced Cell Counting Techniques
           7.11.3 Cell Counting Market, By Type
                    7.11.3.1 Automated Cell Counters
                    7.11.3.2 Hemocytometers and Manual Cell Counters
           7.11.4 Market Share Analysis, By Key Player
    7.12 Next-Generation Sequencing (NGS)
           7.12.1 Drivers
                    7.12.1.1 Focus on Technological Advancements in Sequencing Platforms
                    7.12.1.2 Increasing Applications of NGS
                    7.12.1.3 Conferences and Workshops Increasing Awareness on NGS Products and Services
                    7.12.1.4 Growing Partnerships and Collaborations
           7.12.2 Restraints
                    7.12.2.1 Accuracy & Standardization Concerns in Diagnostic Testing
           7.12.3 Market Share Analysis, By Key Player
    7.13 Western Blotting
           7.13.1 Drivers
                    7.13.1.1 Technological Advancements and Instrument Automation
                    7.13.1.2 Use of Western Blotting for Antibody Validation
           7.13.2 Restraints
                    7.13.2.1 High Cost of Primary Antibodies
                    7.13.2.2 Emergence of Alternative Technologies
           7.13.3 Western Blotting Market, By Type
                    7.13.3.1 Semi-Automated Instruments
                    7.13.3.2 Automated Instruments
                    7.13.3.3 Manual Instruments
           7.13.4 Market Share Analysis, By Key Player
    7.14 Other Technologies
           7.14.1 Laboratory Freezers
                    7.14.1.1 Freezers
                    7.14.1.2 Refrigerators
                    7.14.1.3 Cryopreservation Systems
           7.14.2 Heat Sterilization
                    7.14.2.1 Moist Heat Sterilization (Autoclaves)
                    7.14.2.2 Dry Heat
           7.14.3 Microplate Systems
                    7.14.3.1 Microplate Readers
                    7.14.3.2 Microplate Dispensers
                    7.14.3.3 Microplate Washers
           7.14.4 Laboratory Balances
           7.14.5 Colorimeters
           7.14.6 Incubators
           7.14.7 Fume Hoods

 

8 Life Science Instrumentation Market, By Application
    8.1 Introduction
    8.2 Research Applications
    8.3 Clinical and Diagnostic Applications
    8.4 Other Applications

 

9 Life Science Instrumentation Market, By End User
    9.1 Introduction
    9.2 Cell Counting
           9.2.1 Research Institutions
           9.2.2 Hospitals and Diagnostic Laboratories
           9.2.3 Pharmaceutical and Biotechnology Companies
           9.2.4 Other End Users
    9.3 Centrifuges
           9.3.1 Hospitals
           9.3.2 Biotechnology and Pharmaceutical Companies
           9.3.3 Academic and Research Institutes
    9.4 Chromatography
           9.4.1 Pharmaceutical Companies and CROs
           9.4.2 Biotechnology and Biopharmaceutical Companies
           9.4.3 Academic Research Laboratories
           9.4.4 Agriculture & Food Industry
           9.4.5 Environmental Testing
           9.4.6 Other End Users
    9.5 Electrophoresis
           9.5.1 Academic Institutions
           9.5.2 Pharmaceutical and Biotechnology Companies
           9.5.3 Research Organizations
           9.5.4 Hospitals and Diagnostic Centers
    9.6 Flow Cytometry
           9.6.1 Pharmaceutical and Biotechnology Companies
           9.6.2 Medical Schools and Academic Institutions
           9.6.3 Hospitals
           9.6.4 Research Institutes
           9.6.5 Clinical Testing Labs
    9.7 Immunoassay
           9.7.1 Hospitals
           9.7.2 Clinical Laboratories
           9.7.3 Pharmaceutical Companies, CROs, and Biotechnology Companies
           9.7.4 Blood Banks
           9.7.5 Academic Research Centers
           9.7.6 Other End Users
    9.8 Liquid Handling and Robotics
           9.8.1 Biotechnology and Pharmaceutical Companies
           9.8.2 Research Institutes
           9.8.3 Hospitals and Private Labs
           9.8.4 Academic Institutes
    9.9 Microscopy
           9.9.1 Academic Institutes
           9.9.2 Industries
           9.9.3 Other End Users
    9.10 Next-Generation Sequencing
           9.10.1 Research Centers and Academic & Government Institutes
           9.10.2 Hospitals and Clinics
           9.10.3 Pharmaceutical and Biotechnology Companies
           9.10.4 Other End Users
    9.11 PCR
           9.11.1 Hospitals and Diagnostic Centers
           9.11.2 Research Laboratories and Academic Institutes
           9.11.3 Pharmaceutical and Biotechnology Companies
           9.11.4 Clinical Research Organizations
           9.11.5 Forensic Laboratories
    9.12 Spectroscopy
           9.12.1 Pharmaceutical Companies, CROs, and Biotechnology Companies
           9.12.2 Food and Beverage Industry
           9.12.3 Environmental Testing
           9.12.4 Industrial Chemistry
           9.12.5 Academic Institutions
           9.12.6 Other End Users
    9.13 Western Blotting
           9.13.1 Research Institutes
           9.13.2 Pharmaceutical and Biotechnology Companies
           9.13.3 Diagnostic Laboratories
    9.14 Other Technologies
           9.14.1 Pharmaceutical Companies, CROs, and Biotechnology Companies
           9.14.2 Research Laboratories
           9.14.3 Academic Institutions
           9.14.4 Others End Users

 

10 Life Science Instrumentation Market, By Region
     10.1 Introduction
     10.2 North America
             10.2.1 Funding in Medical Research May Develop New Application Areas for Analytical Technologies
             10.2.2 Stringent Regulations Driving the Use of Analytical Instruments in Drug Development
             10.2.3 Growing Metabolomics Research in the U.S.
             10.2.4 Conferences, Discussions, Symposiums, & Seminars
     10.3 Europe
             10.3.1 Public-Private Investments in R&D Activities
             10.3.2 Rising Awareness on Advanced Analytical Instruments
             10.3.3 Developing Pharmaceutical Sector in Russia
     10.4 Asia-Pacific
             10.4.1 Strategic Expansions By Key Market Players in Emerging Asian Countries
             10.4.2 Rising Crop Research Studies in Asia
             10.4.3 Government Investments in Chinese Biomedical Industry Driving the Demand for Analytical Instruments
             10.4.4 Singapore, an Important Market for Life Science Instrumentation
             10.4.5 Increasing Conferences, Exhibitions, & Meetings on Analytical Instruments
     10.5 Rest of the World
             10.5.1 Flourishing Biotechnology & Pharmaceutical Markets in Brazil and Mexico
             10.5.2 Increasing R&D Funding in the Latin American Region
             10.5.3 High Prevalence of Hiv in African Region

 

11 Competitive Landscape
     11.1 Introduction
     11.2 Strategic Overview
     11.3 Competitive Situation and Trends
             11.3.1 Product Launches, Enhancements, and Showcase
             11.3.2 Agreements, Partnerships, and Collaborations
             11.3.3 Expansion
             11.3.4 Mergers & Acquisitions
             11.3.5 Other Developments

 

12 Company Profiles
     12.1 Introduction
     12.2 Agilent Technologies, Inc.
     12.3 Danaher Corporation
     12.4 Perkinelmer, Inc.
     12.5 Shimadzu Corporation
     12.6 Thermo Fisher Scientific, Inc.
     12.7 Becton, Dickinson and Company
     12.8 Bio-Rad Laboratories, Inc.
     12.9 Bruker Corporation
     12.10 F. Hoffmann-La Roche Ltd.
     12.11 Waters Corporation

The Global Healthcare Life Science & Chemical Instrumentation Market has been segmented as below:
 
By Technology Analysis

•    Chromatography
•    Electrophoresis
•    DNA sequencers & amplifiers 
•    Lab automation
•    Flow cytometry
•    Spectroscopy
•    Microarray
•    Immunoassay
•    Other instruments
 
By End User Analysis

•    Pharmaceutical
•    Biopharmaceutical& biotechnology companies 
•    Clinical research organizations
•    Academic institutions 
•    Hospitals
•    Clinics& diagnostic laboratories 
•    Forensic science laboratories 
•    Food& agriculture industry 
•    Environmental testing industry
 
By Regional Analysis

•    North America
•    Europe
•    Asia-Pacific
•    Rest of the World

Got a question? We've got answers. If you have some other questions, see our support center.

The market is expected to grow at a CAGR of 6% during the study period (2023-2028)
The Global Healthcare Life Science & Chemical Instrumentation Market is expected to be around US$ 78.20 billion by 2028.
The segment included in Healthcare Life Science & Chemical Instrumentation Market is Technology, End User and region.
Some key players operating in the Healthcare Life Science & Chemical Instrumentation Market include Agilent Technologies Inc., Bio-Rad Laboratories Inc., Becton, Dickinson, & Company, Bruker Corporation, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., PerkinElmer Inc., Danaher Corporation, Shimadzu Corporation
We can offer several formats of the market research reports including, • PDF • PPT • Spreadsheet/ Workbook

Related Reports